• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008.35 岁及以上人类免疫缺陷病毒感染和人类免疫缺陷病毒阴性个体在长期队列研究中同时随访的病因特异性预期寿命,1984-2008 年。
Am J Epidemiol. 2013 Jan 15;177(2):116-25. doi: 10.1093/aje/kws321. Epub 2013 Jan 3.
2
The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts.HAART 对 HIV 感染呼吸并发症的影响:MACS 和 WIHS 队列的纵向趋势。
PLoS One. 2013;8(3):e58812. doi: 10.1371/journal.pone.0058812. Epub 2013 Mar 12.
3
Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study.多中心艾滋病队列研究和妇女机构间HIV研究参与者的死亡率。
Clin Infect Dis. 2007 Jan 15;44(2):287-94. doi: 10.1086/510488. Epub 2006 Dec 12.
4
Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.1984年至2003年加拿大艾伯塔省南部HIV感染者的死亡率及死亡原因变化情况
HIV Med. 2005 Mar;6(2):99-106. doi: 10.1111/j.1468-1293.2005.00271.x.
5
Association between Use of Methadone, Other Central Nervous System Depressants, and QTc Interval-Prolonging Medications and Risk of Mortality in a Large Cohort of Women Living with or at Risk for Human Immunodeficiency Virus Infection.美沙酮、其他中枢神经系统抑制剂的使用与 QTc 间期延长药物与艾滋病毒感染者或艾滋病毒感染风险女性患者死亡率的相关性:一项大型队列研究。
Pharmacotherapy. 2019 Sep;39(9):899-911. doi: 10.1002/phar.2312. Epub 2019 Aug 13.
6
Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy.联合抗逆转录病毒治疗时代感染人类免疫缺陷病毒的女性的死亡原因
Am J Med. 2002 Aug 1;113(2):91-8. doi: 10.1016/s0002-9343(02)01169-5.
7
Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy.既往存在的蛋白尿可预测开始抗逆转录病毒治疗的女性的艾滋病和非艾滋病死亡率。
Antivir Ther. 2011;16(4):591-6. doi: 10.3851/IMP1766.
8
Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.高效抗逆转录病毒治疗时代人类免疫缺陷病毒(HIV)感染成人的死因:肝炎和癌症的新作用,艾滋病的持续影响
Int J Epidemiol. 2005 Feb;34(1):121-30. doi: 10.1093/ije/dyh307. Epub 2004 Nov 23.
9
Determinants of survival following HIV-1 seroconversion after the introduction of HAART.高效抗逆转录病毒治疗(HAART)引入后HIV-1血清转化后的生存决定因素。
Lancet. 2003 Oct 18;362(9392):1267-74. doi: 10.1016/s0140-6736(03)14570-9.
10
Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.高效抗逆转录病毒治疗时代的死亡率:HIV门诊研究中死亡和疾病原因的变化
J Acquir Immune Defic Syndr. 2006 Sep;43(1):27-34. doi: 10.1097/01.qai.0000233310.90484.16.

引用本文的文献

1
Acute nicotine vapor attenuates sensorimotor gating deficits in HIV-1 transgenic rats.急性尼古丁蒸汽可减轻HIV-1转基因大鼠的感觉运动门控缺陷。
Psychopharmacology (Berl). 2025 Feb 24. doi: 10.1007/s00213-025-06761-7.
2
The Intersection of HIV and Pulmonary Vascular Health: From HIV Evolution to Vascular Cell Types to Disease Mechanisms.HIV与肺血管健康的交叉领域:从HIV演变到血管细胞类型再到疾病机制
J Vasc Dis. 2024 Jun;3(2):174-200. doi: 10.3390/jvd3020015. Epub 2024 May 6.
3
Provocative Findings From a Transdiagnostic Counseling Intervention to Improve Psychiatric Comorbidity and HIV Care Engagement Among People With HIV: A Pilot Randomized Clinical Trial.一项针对改善 HIV 感染者共病和 HIV 护理参与的跨诊断咨询干预措施的挑衅性发现:一项试点随机临床试验。
J Acquir Immune Defic Syndr. 2024 Sep 1;97(1):68-77. doi: 10.1097/QAI.0000000000003457.
4
The Era of DAAs: Assessing the Patients' Characteristics, Clinical Impact, and Emergence of Comorbidities in HIV/HCV-Coinfected versus HIV-Infected Individuals.直接抗病毒药物时代:评估HIV/HCV合并感染与HIV感染个体的患者特征、临床影响及合并症的出现情况。
J Clin Med. 2024 Jul 4;13(13):3936. doi: 10.3390/jcm13133936.
5
Acute nicotine vapor normalizes sensorimotor gating and reduces locomotor activity deficits in HIV-1 transgenic rats.急性尼古丁蒸汽可使HIV-1转基因大鼠的感觉运动门控正常化,并减少其运动活动缺陷。
bioRxiv. 2024 Jun 22:2024.06.18.599641. doi: 10.1101/2024.06.18.599641.
6
Life course history of physical and sexual abuse is associated with cardiovascular disease risk among women living with and without HIV.身体和性虐待的生活史与艾滋病毒感染者和非感染者的心血管疾病风险相关。
AIDS. 2024 Apr 1;38(5):739-750. doi: 10.1097/QAD.0000000000003822. Epub 2023 Dec 20.
7
Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV.不同抗逆转录病毒治疗时代HIV感染者的癌症发病率趋势
Cancers (Basel). 2023 Jul 15;15(14):3640. doi: 10.3390/cancers15143640.
8
Novel Perspectives on the Design and Development of a Long-Acting Subcutaneous Raltegravir Injection for Treatment of HIV-In Vitro and In Vivo Evaluation.用于治疗HIV的长效皮下注射拉替拉韦设计与开发的新视角——体外和体内评价
Pharmaceutics. 2023 May 18;15(5):1530. doi: 10.3390/pharmaceutics15051530.
9
Hypertension and one-year risk of all-cause mortality among women with treated HIV in the United States.美国接受治疗的 HIV 女性中高血压与全因死亡率的一年风险。
AIDS. 2023 Mar 15;37(4):679-688. doi: 10.1097/QAD.0000000000003461. Epub 2022 Dec 23.
10
[Retention in care and distance between home and hospital in HIV patients of Buenos Aires City].[布宜诺斯艾利斯市艾滋病患者的治疗依从性及家庭与医院的距离]
Actual SIDA Infectol. 2018 Dec;26(98):54-60. doi: 10.52226/revista.v26i98.21.

本文引用的文献

1
Non-injection drug use and HIV disease progression in the era of combination antiretroviral therapy.非注射吸毒与联合抗逆转录病毒治疗时代的 HIV 疾病进展。
J Subst Abuse Treat. 2011 Jun;40(4):386-96. doi: 10.1016/j.jsat.2011.01.001. Epub 2011 Feb 24.
2
Alcohol consumption among HIV-infected women: impact on time to antiretroviral therapy and survival.HIV 感染女性的饮酒行为:对开始抗逆转录病毒治疗和生存时间的影响。
J Womens Health (Larchmt). 2011 Feb;20(2):279-86. doi: 10.1089/jwh.2010.2043. Epub 2011 Jan 31.
3
HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies.HIV/HCV 合并感染:发病机制、临床并发症、治疗和新的治疗技术。
Curr HIV/AIDS Rep. 2011 Mar;8(1):12-22. doi: 10.1007/s11904-010-0071-3.
4
Inference for mutually exclusive competing events through a mixture of generalized gamma distributions.通过广义伽马分布的混合进行互斥竞争事件的推断。
Epidemiology. 2010 Jul;21(4):557-65. doi: 10.1097/EDE.0b013e3181e090ed.
5
Examination of inequalities in HIV/AIDS mortality in the United States from a fundamental cause perspective.从根本原因角度考察美国艾滋病死亡率的不平等现象。
Am J Public Health. 2010 Jun;100(6):1053-9. doi: 10.2105/AJPH.2009.170241. Epub 2010 Apr 19.
6
Proportional subdistribution hazards modeling offers a summary analysis, even if misspecified.比例子分布风险模型提供了一种总结分析,即使有指定错误。
Stat Med. 2010 Mar 30;29(7-8):875-84. doi: 10.1002/sim.3786.
7
Effect of cigarette smoking on HIV acquisition, progression, and mortality.吸烟对HIV感染、病情进展及死亡率的影响。
AIDS Educ Prev. 2009 Jun;21(3 Suppl):28-39. doi: 10.1521/aeap.2009.21.3_supp.28.
8
Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation.癌症:人类免疫缺陷病毒及抗逆转录病毒疗法的影响,以及早期开始抗逆转录病毒疗法的意义。
Curr Opin HIV AIDS. 2009 May;4(3):183-7. doi: 10.1097/COH.0b013e328329c5b2.
9
Trends in mortality and causes of death among women with HIV in the United States: a 10-year study.美国感染艾滋病毒女性的死亡率及死亡原因趋势:一项为期10年的研究。
J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):399-406. doi: 10.1097/QAI.0b013e3181acb4e5.
10
Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status.按CD4细胞计数和高效抗逆转录病毒治疗(HAART)使用状况划分的HIV感染患者中与HIV感染或艾滋病无关的合并症发生率。
Clin Infect Dis. 2008 Oct 15;47(8):1102-4. doi: 10.1086/592115.

35 岁及以上人类免疫缺陷病毒感染和人类免疫缺陷病毒阴性个体在长期队列研究中同时随访的病因特异性预期寿命,1984-2008 年。

Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008.

机构信息

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Room E7648, Baltimore, MD 21205, USA.

出版信息

Am J Epidemiol. 2013 Jan 15;177(2):116-25. doi: 10.1093/aje/kws321. Epub 2013 Jan 3.

DOI:10.1093/aje/kws321
PMID:23287403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3590031/
Abstract

Parametric and semiparametric competing risks methods were used to estimate proportions, timing, and predictors of acquired immune deficiency syndrome (AIDS)-related and non-AIDS-related mortality among individuals both positive and negative for the human immunodeficiency syndrome (HIV) in the Multicenter AIDS Cohort Study (MACS) and Women's Interagency HIV Study (WIHS) from 1984 to 2008 and 1996 to 2008, respectively. Among HIV-positive MACS participants, the proportion of deaths unrelated to AIDS increased from 6% before the introduction of highly active antiretroviral therapy (HAART) (before 1996) to 53% in the HAART era (P < 0.01); the median age of persons who died from non-AIDS-related causes after age 35 years increased from 49.0 to 66.0 years (P < 0.01). In both cohorts during the HAART era, median ages at time of non-AIDS-related death were younger for HIV-positive individuals than for comparable HIV-negative individuals (8.7 years younger in MACS (P < 0.01) and 7.6 years younger in WIHS (P < 0.01)). In a multivariate proportional cause-specific hazards model, unemployment (for non-AIDS death, hazard ratio (HR) = 1.8; for AIDS death, HR = 2.3), depression (for non-AIDS death, HR = 1.4; for AIDS death, HR = 1.4), and hepatitis B or C infection (for non-AIDS death, HR = 1.8, for AIDS death; HR = 1.4) were significantly (P < 0.05) associated with higher hazards of both non-AIDS and AIDS mortality among HIV-positive individuals in the HAART era, independent of study cohort. The results illuminate the changing face of mortality among the growing population infected with HIV.

摘要

采用参数和半参数竞争风险方法,估算了 1984 年至 2008 年期间在多中心艾滋病队列研究(MACS)和妇女艾滋病机构间研究(WIHS)中人类免疫缺陷病毒(HIV)阳性和阴性个体中获得性免疫缺陷综合征(AIDS)相关和非 AIDS 相关死亡率的比例、时间和预测因素。在 MACS 中的 HIV 阳性参与者中,在开始高效抗逆转录病毒治疗(HAART)之前(1996 年之前),与 AIDS 无关的死亡比例从 6%增加到 HAART 时代的 53%(P<0.01);35 岁以后死于非 AIDS 相关原因的人的中位数年龄从 49.0 岁增加到 66.0 岁(P<0.01)。在 HAART 时代,两个队列中,HIV 阳性个体的非 AIDS 相关死亡的中位年龄均比可比的 HIV 阴性个体年轻(MACS 中年轻 8.7 岁(P<0.01),WIHS 中年轻 7.6 岁(P<0.01))。在多变量比例原因特异性危害模型中,失业(非 AIDS 死亡,危害比(HR)=1.8;AIDS 死亡,HR=2.3)、抑郁(非 AIDS 死亡,HR=1.4;AIDS 死亡,HR=1.4)和乙型或丙型肝炎感染(非 AIDS 死亡,HR=1.8,AIDS 死亡,HR=1.4)与 HAART 时代 HIV 阳性个体的非 AIDS 和 AIDS 死亡率升高显著相关(P<0.05),与研究队列无关。这些结果阐明了在感染 HIV 的不断增长的人群中死亡率的变化。